Caplacizumab 68225-0256-00
- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 6, 2019
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Caplacizumab | 11 mg/mL |
Selected Package
68225-0256-00Selected126 CARTON in 1 CONTAINER (68225-256-00) / 247 VIAL in 1 CARTON / 2 mL in 1 VIAL